FDA Inspection
Somerset Therapeutics LimitedSomerset Therapeutics Limited – FDA Inspection, Feb 21, 2025
Record Details
This FDA Inspection record concerns Somerset Therapeutics Limited, with an inspection on February 21, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fe96a3fc-4617-4a2b-83f9-bbbc164238f5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1261727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Somerset Therapeutics Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Somerset Therapeutics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.